Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis
about
Toxicity of MRI and CT contrast agentsN-acetylcysteine -- passe-partout or much ado about nothing?Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.Prophylaxis of contrast-induced nephrotoxicityRadiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategiesCompliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study.A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.Contrast induced nephropathy in urology.Contrast-induced nephropathy in patients undergoing percutaneous coronary interventionCardiological Society of India practice guidelines for angiography in patients with renal dysfunction.Contrast-induced acute kidney injury: short- and long-term implications.Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography.Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathyDoes safe dosing of iodinated contrast prevent contrast-induced acute kidney injury?Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathyContrast medium-induced nephropathy: strategies for prevention.N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.TACE versus TAE as therapy for hepatocellular carcinoma.Pharmacological strategies to prevent contrast-induced acute kidney injury.Contrast-induced nephropathy: protective role of fenoldopam.Accuracy of point-of-care serum creatinine devices for detecting patients at risk of contrast-induced nephropathy: a critical overview.Systematic reviews and meta-analyses of randomized trials: principles and pitfalls.Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.BMC Medicine celebrates its 5th anniversary.Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty
P2860
Q22306013-7BA2EF9F-A2C4-4569-9587-3A8B9FB90B20Q24678741-A26F13F0-2157-4DCD-8279-6D3632A76584Q26823226-73E70882-D564-4ACD-8C0A-6241CF5184DBQ27012899-27C7B428-417B-425B-B405-A0FD24CD5C05Q27021421-091911E1-7838-44EE-BE8F-F79933DA888DQ30476674-BB1B2915-3B43-4263-82CA-C774B4025406Q33305487-0C6553C2-6AA0-45D6-B8F8-C3D24587BFD4Q33599720-F12C43F4-72EF-4E40-A900-A19BF8BFDB48Q34155673-DF0BE3BD-5B09-4C09-B19B-4AFF92CAD099Q34574872-A346D700-CA87-4A61-95B0-71BBD2E8D818Q35127308-5E09CF0E-F2F4-458E-98F9-0E6DF8FBB5F6Q35999430-3EDC6AE9-2EAF-4F1B-AA25-777860C566B8Q36389997-522B8794-DD33-4915-957B-0AEE59CDA825Q36832391-4AEDF85D-7F44-4FCA-832E-538702889C9EQ37251655-6051E428-C937-446F-85BA-EE06349569EBQ37254460-FD2E3A82-E720-46E3-B7F2-FB4B93ACDBC1Q37271293-2261A357-3347-4503-908C-0D01234FB064Q37300023-ADA36065-2FE0-44DC-8689-2FA67CAF7832Q37639849-86D770A3-BB98-4183-B152-C1313889EA9BQ38014116-85FB6F01-987A-4440-861F-62EF47E61593Q38230626-A658D0F0-D98C-494B-8FF8-53218F63A0C9Q38270447-7C2919F9-14FE-4949-BEAC-B57389146DC3Q45956376-BEB32608-16E5-432E-8EC2-BE4B76BD3CD4Q46102219-499AC55D-71F8-4728-B78E-D93912AC75FFQ57448723-B1E0EF79-1109-4634-BCC8-A8A56A2AC00B
P2860
Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Acetylcysteine for prevention ...... matic review and meta-analysis
@ast
Acetylcysteine for prevention ...... matic review and meta-analysis
@en
Acetylcysteine for prevention ...... matic review and meta-analysis
@nl
type
label
Acetylcysteine for prevention ...... matic review and meta-analysis
@ast
Acetylcysteine for prevention ...... matic review and meta-analysis
@en
Acetylcysteine for prevention ...... matic review and meta-analysis
@nl
prefLabel
Acetylcysteine for prevention ...... matic review and meta-analysis
@ast
Acetylcysteine for prevention ...... matic review and meta-analysis
@en
Acetylcysteine for prevention ...... matic review and meta-analysis
@nl
P2860
P31
P921
P356
P1433
P1476
Acetylcysteine for prevention ...... matic review and meta-analysis
@en
P2093
Sean M Bagshaw
William A Ghali
P2860
P2888
P356
10.1186/1741-7015-2-38
P407
P577
2004-10-22T00:00:00Z
P5875
P6179
1013554264